Access by design.
Medicines.
Access.
Health Outcomes.
Where access begins with people.
What we do
Pharma and biotech innovation can only deliver its promise when payers recognize value and healthcare systems are ready to adopt it.
We align evidence, market realities, and organizational capabilities so innovative products are reimbursed, rewarded, and accessible to patients.
Who we work with
Pharma and biotech leaders
scaling value and access across markets.
Biotech innovators
looking to upskill or entering new geographies.
Investors
assessing value and access risk and opportunity.
Healthcare organizations
seeking partners to improve patient access.
Why Convalentis
Boardroom credibility
Global access leadership experience.
Executional depth
Strategies that hold up in practice.
Independent perspective
Clear roles, tailored advice, aligned with context.
We help you
Plan
for payers and policy
expectations early.
Build
compelling value stories that
stand up with decision-makers.
Capture
value with access strategies, partnerships,
pricing, and deal structures.
Grow
organizational capabilities and
governance that delivers.
Our Concept
Access Architecture™
Plan · Build · Capture · Grow
A systematic way to translate innovation into sustainable access and value.
Explore how we
could work
together